Drawing based on the label description. No photo yet.
93 E9 pill
Pill with imprint 93 E9 is blue, round, 6 mm and has been identified as Eszopiclone 3 mg. It is supplied by Unit Dose Services.
Controlled substance: Schedule IV
Eszopiclone 3 mg
- Imprint
- 93 E9
- Strength
- 3 mg
- Color
- Blue
- Shape
- Round
- Size
- 6 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Unit Dose Services
- NDC
- 50436-5539, 0093-5539, 50436-5539-1, 71610-409, 71610-409-30, 0093-5539-01
Is this your pill? Check every detail
- The imprint reads exactly 93 E9, on the same sides.
- It is blue, round, 6 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Eszopiclone
Inactive: Silicon Dioxide, Croscarmellose Sodium, Anhydrous Dibasic Calcium Phosphate, Hypromellose 2910 (6 Mpa.s), Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol 400, Titanium Dioxide, Fd&c Blue No. 2, Indigotindisulfonate Sodium, Aluminum Oxide
Also distributed by
Aphena Pharma Solutions - Tennessee, LLC, Teva Pharmaceuticals Usa, Inc.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
APO MID 10
Midodrine Hydrochloride 10 mg
Blue, round, 7 mm
-
K 9
Oxycodone Hydrochloride 30 mg
Blue, round, 6 mm
Schedule II
-
L24
Levothyroxine Sodium 0.15 mg
Blue, round, 6 mm
-
020
Nadolol 20 mg
Blue, round, 7 mm
-
I 157
Propranolol Hydrochloride 20 mg
Blue, round, 6 mm
-
ABG 15
Morphine Sulfate 15 mg
Blue, round, 7 mm
Schedule II
Other Eszopiclone pills
- 382 G Eszopiclone 1 mg Blue, round, 6 mm Schedule IV
- 382 G Eszopiclone 3 mg Blue, round, 6 mm Schedule IV
- 383 G Eszopiclone 2 mg White, round, 6 mm Schedule IV
- 384 G Eszopiclone 3 mg Blue, round, 6 mm Schedule IV
- 54 396 Eszopiclone 3 mg White, round, 9 mm Schedule IV
- 93 E7 Eszopiclone 1 mg Blue, round, 6 mm Schedule IV
- 93 E8 Eszopiclone 2 mg White, round, 6 mm Schedule IV
- E 1 Eszopiclone 1 mg Blue, round, 6 mm Schedule IV